Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.
Stefano LuzzagoMattia Luca PiccinelliGiulia MarvasoEkaterina LaukhtinaNoriyoshi MiuraVictor M SchuettfortKeiichiro MoriAbdulmajeed AydhMatteo FerroFrancesco A MistrettaNicola FuscoGiuseppe PetraliaBarbara A Jereczek-FossaShahrokh F ShariatPierre I KarakiewiczOttavio de CobelliGennaro MusiPublished in: World journal of urology (2021)
AS represents a safe management strategy for IPCa. Compared to BxPCa, IPCa patients are less prone to experience any-cause and biopsy/MRI AS discontinuation. However, the two mentioned groups present similar rates of biopsy discontinuation and ISUP GG upgrading over time. In consequence, tailored AS protocols with scheduled repeated surveillance biopsies should be offered to all newly diagnosed IPCa patients.